BIOLASE, Inc. (BIOL) |
| 0.02 0.004 (27.39%) 10-02 16:00 |
| Open: | 0.049 |
| High: | 0.052 |
| Low: | 0.0157 |
| Volume: | 2,672,966 |
| Market Cap: | 1(M) |
| PE Ratio: | 0 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 21.31 |
| Resistance 1: | 18.32 |
| Pivot price: | 15.76 |
| Support 1: | 13.48 |
| Support 2: | 11.22 |
| 52w High: | 1.94 |
| 52w Low: | 0.0157 |
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, pain therapy, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Mon, 07 Oct 2024
BIOLASE Files for Chapter 11, Pursues Asset Sale to Sonendo - Dentistry Today
Wed, 02 Oct 2024
Biolase stock in flux as company files for bankruptcy - Investing.com
Tue, 18 Jun 2024
BIOLASE Announces Delisting from Nasdaq - Yahoo Finance
Mon, 13 May 2024
Biolase Inc (BIOL) Q1 2024 Earnings Call Transcript Highlights: Strategic Gains Amidst Economic Challenges - GuruFocus
Thu, 15 Feb 2024
BIOLASE, Inc. Announces Closing of $7.0 Million Public Offering - Yahoo Finance
Thu, 14 Dec 2023
Indo-Asian News Service - IANS
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |